title: Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
abstract: Blocking the interaction between phosphotyrosine (pTyr)-containing activated receptors and the Src homology 2 (SH2) domain of the growth factor receptor bound protein 2 (Grb2) is considered to be an effective and non-cytotoxic strategy to develop new anti-proliferative agents due to its potential to shut down the Ras activation pathway. Generally, the pTyr-X-Asn minimal binding motif is required for a high-affinity ligand binding to the Grb2-SH2 domain. Using phage-display techniques, we discovered a non-pTyr-containing cyclic peptide G1 with moderate binding affinity from 10(7) different sequences. To understand the structural basis for the high-affinity binding of these novel non-phosphorus-containing inhibitors to the Grb2-SH2 domain, we extensively studied herein the unique functional requirements of the acidic side chain in Tyr-2 position due to the absence of the phosphate group in these non-phosphorylated peptides. A comprehensive SAR study was also carried out to develop potent Grb2-SH2 domain antagonists based upon this novel template. With both the peptidomimetic optimization of the amino acid side-chains and the constraint of the backbone conformation guided by molecular modeling, we developed several potent antagonists with low nanomolar range binding affinity, such as cyclic peptide 20 with an IC(50)=0.026 microM, which is one of the most potent non-phosphorus-containing Grb2-SH2 antagonists reported to date. Whole cell assays indicate that peptide 20 can penetrate the cell membranes and inhibit the association of Grb2 with p185(erbB2) in erbB2-overexpressing MDA-MA-453 cancer cells at low micromolar concentrations.
authors.affiliation: Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, 376 Boyles Street, Frederick, MD 21702-1201, USA.
authors.forename: Peng
authors.initials: P
authors.lastname: Li
authors.forename: Manchao
authors.initials: M
authors.lastname: Zhang
authors.forename: Megan L
authors.initials: ML
authors.lastname: Peach
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Zhang
authors.forename: Hongpeng
authors.initials: H
authors.lastname: Liu
authors.forename: Marc
authors.initials: M
authors.lastname: Nicklaus
authors.forename: Dajun
authors.initials: D
authors.lastname: Yang
authors.forename: Peter P
authors.initials: PP
authors.lastname: Roller
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000596:Amino Acids / Q000737:chemistry; D024342:Amino Acids, Acidic / Q000737:chemistry; D000818:Animals; D001665:Binding Sites; D051380:GRB2 Adaptor Protein; D057927:Hydrophobic and Hydrophilic Interactions; D008958:Models, Molecular; D010456:Peptides, Cyclic / Q000737:chemistry* / Q000378:metabolism* / Q000494:pharmacology; D010748:Phosphopeptides / Q000378:metabolism; D011485:Protein Binding; D011506:Proteins / Q000737:chemistry* / Q000378:metabolism; D014407:Tumor Cells, Cultured; D018909:src Homology Domains
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D000596:Amino Acids; D024342:Amino Acids, Acidic; C403002:G1TE cyclic peptide; D051380:GRB2 Adaptor Protein; D010456:Peptides, Cyclic; D010748:Phosphopeptides; D011506:Proteins